Roger C Fu

US Patent:

8415401, Apr 9, 2013

Filed:

Dec 5, 2008

Appl. No.:

12/315868

Inventors:

Su Il Yum - Los Altos CA, US
Wendy Chao - San Jose CA, US
Roger Fu - Saratoga CA, US
Michael Zamloot - Hillsborough CA, US

Assignee:

Durect Corporation - Cupertino CA

International Classification:

A61K 47/00

US Classification:

514781, 514777, 514785, 514724, 514183

Abstract:

Abuse-resistant oral dosage forms suitable for administration of pharmacologically active agents are provided.

US Patent:

20090298862, Dec 3, 2009

Filed:

Aug 7, 2009

Appl. No.:

12/315740

Inventors:

Su Il Yum - Los Altos CA, US
Wendy Chao - San Jose CA, US
Roger Fu - Saratoga CA, US
Michael Zamloot - Hillsborough CA, US

International Classification:

A61K 31/4355
A61K 31/34

US Classification:

514282, 514468

Abstract:

Methods, including those for administering novel pharmaceutical compositions, dosage forms containing an opioid active pharmaceutical ingredient, are useful for treating pain, arthritic conditions and/or inflammation associated with a chronic condition, including pain from arthritis and inflammation.

US Patent:

20130317049, Nov 28, 2013

Filed:

Oct 22, 2012

Appl. No.:

13/657655

Inventors:

Wendy Chao - San Jose CA, US
Roger Fu - Saratoga CA, US
Michael Zamloot - Hillsborough CA, US

Assignee:

Durect Corporation - Cupertino CA

International Classification:

A61K 31/485

US Classification:

514282

Abstract:

Methods, including those for administering novel pharmaceutical compositions, dosage forms containing an opioid active pharmaceutical ingredient, are useful for treating pain, arthritic conditions and/or inflammation associated with a chronic condition, including pain from arthritis and inflammation.

US Patent:

20130337059, Dec 19, 2013

Filed:

Mar 5, 2013

Appl. No.:

13/786217

Inventors:

Wendy Chao - San Jose CA, US
Roger Fu - Saratoga CA, US
Michael Zamloot - Hillsborough CA, US

Assignee:

Durect Corporation - Cupertino CA

International Classification:

A61K 31/485
A61K 9/48

US Classification:

424456, 514282, 424451

Abstract:

Abuse-resistant oral dosage forms suitable for administration of pharmacologically active agents are provided.

US Patent:

20130337060, Dec 19, 2013

Filed:

Mar 5, 2013

Appl. No.:

13/786218

Inventors:

Wendy Chao - San Jose CA, US
Roger Fu - Saratoga CA, US
Michael Zamloot - Hillsborough CA, US

Assignee:

Durect Corporation - Cupertino CA

International Classification:

A61K 31/485
A61K 31/137
A61K 9/48

US Classification:

424456, 514282, 514654

Abstract:

Abuse-resistant oral dosage forms suitable for administration of pharmacologically active agents are provided.

US Patent:

55434088, Aug 6, 1996

Filed:

Dec 5, 1994

Appl. No.:

8/349236

Inventors:

Roger C. Fu - Saratoga CA
Jeffrey S. Fleitman - Sunnyvale CA
Michele C. Rizzolio - Durham NC
Andrew R. Miksztal - Menlo Park CA

Assignee:

Syntex (U.S.A.) Inc. - Palo Alto CA

International Classification:

A61K 31535
C07D41312

US Classification:

5142335

Abstract:

The crystalline anhydrous salt formed by complexing mycophenolate mofetil with an anion selected from the group chloride, sulfate, phosphate and acetate (in particular the hydrochloride salt), and pharmaceutical compositions, intravenous formulations and a kit thereof, and associated methods of treatment.

US Patent:

60253266, Feb 15, 2000

Filed:

Nov 21, 1996

Appl. No.:

8/752853

Inventors:

Deborah A. Steinberg - Saratoga CA
De Hwa Chao - San Jose CA
David J. Loury - San Jose CA
Roger Cherng Fu - Saratoga CA
Chee Liang Gu - Saratoga CA
Conway C. Chang - San Francisco CA
John C. Fiddes - Palo Alto CA

Assignee:

IntraBiotics Pharmaceuticals, Inc. - Mountain View CA

International Classification:

A61K 716
A61K 968
C07K 708
C07K 702

US Classification:

514 2

Abstract:

The present invention provides methods and compositions suitable for treating oral mucositis in animals, including humans, with antimicrobial peptides such as protegrin peptides.

US Patent:

55456375, Aug 13, 1996

Filed:

Jun 2, 1995

Appl. No.:

8/459991

Inventors:

Roger C. Fu - Saratoga CA
Jeffrey S. Fleitman - Sunnyvale CA
Michele C. Rizzolio - Durham NC
Andrew R. Miksztal - Menlo Park CA

Assignee:

Syntex (U.S.A.) Inc. - Palo Alto CA

International Classification:

A61K 31535

US Classification:

5142335

Abstract:

The crystalline anhydrous salt formed by complexing mycophenolate mofetil with an anion selected from the group chloride, sulfate, phosphate and acetate (in particular the hydrochloride salt), and pharmaceutical compositions, intravenous formulations and a kit thereof, and associated methods of treatment.